title: [Chronic autoimmune urticaria: treatment with omalizumab].
abstract: We report the case of a child with diagnosis of chronic urticaria/angioedema and its evolution upon omalizumab treatment.
  
  
  METHODS
  Our patient is a 12-years-old female who suffered for 14 months severe chronic urticaria/angioedema. She had a poor response to the highest doses of combined therapy with 3 antihistamines, steroids and anti-leukotrienes and great impairment of her quality of life. An autologous serum skin test was positive until 1:100 dilutions, leading to the diagnosis of chronic autoimmune urticaria. Due to the lack of response to treatment, therapy with omalizumab was administered. A notable reduction in symptoms toward the third dose was observed. After 12 months of this treatment, the patient is asymptomatic and has a negative autologous serum test.
  
  
  CONCLUSIONS
  Omalizumab could be a therapeutic option for patients with autoimmune urticaria unresponsive to other treatments.
authors.affiliation: Alergia Infantil, Hospital Alemán.
authors.forename: Jorge F
authors.initials: JF
authors.lastname: Máspero
authors.forename: Claudio A
authors.initials: CA
authors.lastname: Parisi
authors.forename: Mónica
authors.initials: M
authors.lastname: De Gennaro
authors.forename: Osvaldo
authors.initials: O
authors.lastname: Benhabib
authors.forename: Marta
authors.initials: M
authors.lastname: Lampert
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D005260:Female; D006801:Humans; D000069444:Omalizumab; D014581:Urticaria / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab